WendlerD. Commentary: innovative approaches to informed consent for randomized clinical trials: identifying the ethical challenges. Clin Trials2018; 15: 17–20.
2.
WeijerCGoldsteinCTaljaardM. Commentary: TwiC or Treat? Are trials within cohorts ethically defensible?Clin Trials2018; 15: 21–24.
3.
ChristensenL. Deception in psychological research: when is its use justified?Pers Soc Psychol Bull1988; 14: 664–675.
4.
JoffeSCookEFClearyPDet al. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet2001; 358: 1772–1777.
5.
BeardsleyEJeffordMMileshkinL. Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening?J Clin Oncol2007; 25: e13–e14.
6.
BergerOGronbergBHSandKet al. The length of consent documents in oncological trials is doubled in twenty years. Ann Oncol2009; 20: 379–385.
7.
CheungWYPondGRHeslegraveRJet al. The contents and readability of informed consent forms for oncology clinical trials. Am J Clin Oncol2010; 33: 387–392.
8.
VickersAJYoung-AfatDAEhdaieBet al. Just-in-time consent: the ethical case for an alternative to traditional informed consent in randomized trials comparing an experimental intervention with usual care. Clin Trials2018; 15: 3–8.
